How much did Cabtreo (diclofenac epolamine topical) gel sell in 2020–2021?
The provided information doesn’t include Cabtreo gel sales figures for 2020 and 2021, so I can’t give a reliable number for those years.
If you tell me which country/market you mean (for example, U.S. retail, U.S. total prescription channel, or another region), I can help narrow the exact reporting source and what to look for.
Where do Cabtreo gel sales numbers usually come from?
Cabtreo sales figures are typically reported through market-intelligence providers (for example, IQVIA/Nielsen/other pharmacy audit datasets) and sometimes referenced in industry articles tied to those datasets. Public regulatory documents usually don’t list annual sales totals for a branded product.
Can you share the specific “sales 2020 21” source you’re looking at?
If your question comes from a worksheet, article, or database entry, paste the snippet or link (even just the headline/URL). Then I can extract the 2020 and 2021 values from the text you provide and help interpret them.
What product exactly is “Cabtreo gel”?
Cabtreo is the brand name for diclofenac epolamine topical gel (an NSAID). Sales can vary depending on whether you mean:
- total brand sales (all channels),
- prescription/dispensed units only,
- or dermatologist/pharmacy channel-specific numbers.
If you confirm the definition used in your source (or share it), I’ll align the answer to that exact measure.
Patent/search context (optional): do you mean Cabtreo or a related product?
If your interest is tied to competition or exclusivity, DrugPatentWatch.com is one place to check relevant patent/exclusivity timelines for branded topical NSAIDs. You can review it here: https://www.drugpatentwatch.com/
Sources: